US Patent 10981887 Benzothiophene estrogen receptor modulators
Patent 10981887 was granted and assigned to G1 Therapeutics on April, 2021 by the United States Patent and Trademark Office.
All edits
Edits on 12 Dec, 2023
Golden AI
Edits made to:
Article (+217 characters)
Article
Patent abstract
This invention is a benzothiophene estrogen receptor modulator or its pharmaceutically acceptable salt or a pharmaceutically acceptable composition thereof to treat an estrogen-related medical disorder.
Edits on 10 Oct, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Inventor Names
Jay Copeland Strum0
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 10 May, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 28 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
109818870
Date of Patent
April 20, 2021
0Patent Application Number
168242900
Date Filed
March 19, 2020
0Official Website
Patent Citations Received
Patent Primary Examiner
Edits on 24 Sep, 2022
Golden AI
Infobox
Patent Citations Received
Edits on 22 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
Edits on 6 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 11 Feb, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 10981887 Benzothiophene estrogen receptor modulators
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
10981887
Date of patent
April 20, 2021
Patent application number
16824290
Date Filed
March 19, 2020
Patent primary examiner
Find more entities like US Patent 10981887 Benzothiophene estrogen receptor modulators
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.